GH Secretagogue Peptide
CJC-1295 with DAC
Long-acting GHRH analog with drug affinity complex.
$69.00
Free shipping on orders over $300 · Same-day dispatch before 2PM EST
Select Option
Volume Discounts
Don't forget your reconstitution solution
Bacteriostatic Water 30mL
$25.00
Purchase Options
Lab Verified
HPLC-MS + endotoxin
Same-Day Ship
Orders by 2PM EST
Damage Coverage
Free replacement
Discreet Packaging
Plain outer box
Research Use Only
Not for human or veterinary consumption. For laboratory and in-vitro research purposes only.
Total
$69.00
Description
Modified GHRH analog incorporating a drug affinity complex (DAC) for extended half-life in research models.
Reconstitution
Reconstitute with bacteriostatic water in your preferred ratio. Store reconstituted vials refrigerated (2–8 °C) and use within recommended timeframes for your protocol.
Storage
Unreconstituted lyophilized powder stable at room temperature for short periods; refrigerate (2–8 °C) for long-term storage. Avoid repeat freeze/thaw cycles.
- Dose
- 2mg
- Purity
- ≥ 99%
- Form
- Lyophilized powder
- Storage
- Refrigerate after reconstitution
- Origin
- USA — synthesized & shipped domestically
- Testing
- HPLC-MS, MALDI, endotoxin screen
Certificate of analysis available on request
The batch certificate for this item isn't published online yet. Request it here and we'll email you the lab report for the batch you receive.
Research Overview
CJC-1295 with DAC is a modified 30-amino-acid GHRH analog incorporating a Drug Affinity Complex (DAC). The DAC chemistry forms a covalent bond with circulating albumin, dramatically extending the peptide's research half-life relative to native GHRH or sermorelin.
The result is a long-acting tool compound that produces sustained elevations in baseline GH release in laboratory models, useful for studying chronic-exposure pharmacology of the GHRH receptor.
Mechanism of Action
Activates the GHRH receptor at the pituitary; the DAC moiety couples to serum albumin via a maleimidopropionic acid linker, prolonging circulation and producing extended receptor exposure in research settings.
Research Applications
- Long-acting GHRH receptor research
- Sustained GH-axis exposure studies
- Albumin-binding peptide pharmacology
Reconstitution & Handling
Certificate of Analysis
Lot / Batch
QP-2025-3153
- Product
- CJC-1295 with DAC
- Manufacture date
- 2025-06-10
- Test date
- 2025-06-13
- Expiration
- 2028-06-10
- Appearance
- White to off-white lyophilized powder
- Identity
- Confirmed — matches reference standard
- Purity (HPLC)
- 99.90%
- Water content (KF)
- 1.30%
- Endotoxin (LAL)
- < 0.08 EU/mg
- Bioburden
- < 1 CFU / vial
- Analytical methods
- RP-HPLC, ESI-MS, MALDI-TOF, LAL endotoxin assay
- Released by
- QPUSA Quality Assurance Lab
Related products
